Brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by STAT3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets
SABRINA L. ZELLER(Westchester Medical Center), Meena Jhanwar‐Uniyal(Westchester Medical Center)
Cited by 2
Related Papers
Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid
|Oncology Reports|2013|49
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
|International Journal of Oncology|2021|29
Molecular Sequence of Events and Signaling Pathways in Cerebral Metastases
|Anticancer Research|2018|12